A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets
- Resource Type
- Article
- Source
- In
Gynecologic Oncology 2003 90(3):529-536 - Subject
- Language
- ISSN
- 0090-8258